publicações

Revistas Internacionais com Arbitragem Científica

 

Trends in gastric and esophageal cancer incidence in northern Portugal (1994-2009) by subsite and histology, and predictions for 2015.

Castro C, Peleteiro B, Bento MJ, Lunet N.

Tumori. 2016 Aug. [Epub ahead of print]

 

Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date.

Castro C, Antunes L, Lunet N, Bento MJ.

Eur J Cancer Prev. 2016 Sep;25(5):472-80.


Incidence of second primary cancers in North Portugal - a population-based study.

Pacheco-Figueiredo L, Antunes L, Bento MJ, Lunet N.

J Cancer Surviv. 2016 Feb;10(1):142-52.

 

Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study.

Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, et al.

Eur J Cancer. 2015 Sep 6 [Epub ahead of print]

 

The EUROCARE-5 study on cancer survival in Europe 1999-2007: database, quality checks and statistical analysis methods.

Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, et al.

Eur J Cancer. 2015 Sep 6 [Epub ahead of print].

 

Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study.

Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D, Licitra L; EUROCARE Working Group.

Eur J Cancer. 2015 Sep 6 [Epub ahead of print].

 

Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5.

Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, et al.

Eur J Cancer. 2015 Sep 5 [Epub ahead of print]

 

On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 - Results from the EUROCARE-5 study.

Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, et al.

Eur J Cancer. 2015 Sep 6 [Epub ahead of print]

 

Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5.

Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, et al.

Eur J Cancer. 2015 Sep 5 [Epub ahead of print]

 

Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study.

Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, et al.

Eur J Cancer. 2015 Sep 5 [Epub ahead of print]

 

Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study.

Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E, et al.

Eur J Cancer. 2015 Sep 5 [Epub ahead of print]

 

Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study.

Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, et al.

Eur J Cancer. 2015 Sep 6 [Epub ahead of print]

 

Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study.

Trama A, Foschi R, Larrañaga N, Sant M, Fuentes-Raspall R, Serraino D, et al.

Eur J Cancer. 2015 Sep 6 [Epub ahead of print]

 

Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5.

Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, et al.

Eur J Cancer. 2015 Sep 5 [Epub ahead of print].

 

Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study.

Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P, et al.

Eur J Cancer. 2015 Sep 5 [Epub ahead of print]

 

Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.

De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, et al.

Eur J Cancer. 2015 Sep 6. [Epub ahead of print]

 

Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.

Bento MJ, Gonçalves G, Aguiar A, Castro C, Veloso V, Rodrigues V.

Cancer Epidemiol. 2015 Oct;39(5):783-9.

 

Childhood central nervous system tumour mortality and survival in Southern and Eastern Europe (1983-2014): Gaps persist across 14 cancer registries.

Karalexi MA, Papathoma P, Thomopoulos TP, Ryzhov A, Zborovskaya A, Dimitrova N, et al.

Eur J Cancer. 2015 Nov; 51(17):2665-77. Epub 2015 Sep 3

 

Childhood central nervous system tumours: Incidence and time trends in 13 Southern and Eastern European cancer registries

Papathoma P, Thomopoulos TP, Karalexi MA, Ryzhov A, Zborovskaya A, Dimitrova N, et al.

Eur J Cancer. 2015 Jul;51(11):1444-55. Epub 2015 May 9.

 

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al.

Lancet. 2015 Mar 14;385(9972):977-1010.

 

Clinicopathological differences between interval and screen-detected breast cancers diagnosed within a screening programme in Northern Portugal.

Bento MJ, Gonçalves G, Aguiar A, Antunes L, Veloso V, Rodrigues V.

J Med Screen. 2014 Jun;21(2):104-9.

 

Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5 a population-based study.

Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al.

Lancet Oncol. 2014; 15(1): 35-47

 

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 a population-based study.

De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D,  et al.

Lancet Oncol. 2014; 15(1): 23-34

 

Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.

Arnold M, Holterhues C, Hollestein LM, Coebergh JW, Nijsten T, Pukkala E, et al.

J Eur Acad Dermatol Venereol. 2014; 28(9): 1170-8.

 

Availability of stage at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for cancer care in Europe: Results of EUROCHIP-3 survey.

Siesling S, Kwast A, Gavin A, Baili P, Otter R; EUROCHIP-3 Workpackage 5.

Int J Cancer. 2013; 132(12): 2910-7


Trends in incidence of breast cancer among women under 40 in seven European countries: a GRELL cooperative study.
Leclère B, Molinié F, Trétarre B, Stracci F, Daubisse-Marliac L, Colonna M.

Cancer Epidemiol. 2013; 37(5): 544-9.

 

Consistency and inconsistency in testing biomarkers in breast cancer. A GRELL study in cut-off variability in the Romance language countries.

Crocetti E, Caldarella A, Ferretti S, Ardanaz E, Arveux P, Bara S, et al.

Breast. 2013; 22(4): 476-81.

 

Evaluation of the frequency of and survival from second primary cancers in North Portugal: a population-based study.

Pacheco-Figueiredo L, Antunes L, Bento MJ, Lunet N.

Eur J Cancer Prev. 2013; 22(6): 599-606.

 

Model-based patterns in prostate cancer mortality worldwide.

Fontes F, Severo M, Castro C, Lourenço S, Gomes S, Botelho F, La Vecchia C, Lunet N.

Br J Cancer, 2013; 108(11): 2354-66.

 

Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal.

Monteiro LS, Antunes L, Bento MJ, Warnakulasuriya S.

J Oral Pathol Med, 2012; 42(4): 345-51.

 

Cancer incidence and survival (1997-2006) among adolescents and young adults in the north of Portugal.

Carreira H, Antunes L, Castro C, Lunet N, Bento MJ.

Pediatr Hematol Oncol, 2012; 29(7): 663-76.


Prediagnosis lifestyle exposures and survival of gastric cancer patients: a cohort study from Portugal.
Ferronha I, Castro C, Carreira H, Bento MJ, Carvalho I, Peleteiro B, Lunet N.
Br J Cancer, 2012; 107(3): 537-43.

Health-related behaviours in the EpiPorto study: cancer survivors versus participants with no cancer history.
Pacheco-Figueiredo L, Antunes L, Bento MJ, Lunet N.
Eur J Cancer Prev, 2011; 20(4): 348-54.


Cartas ao Editor

Assessing the completeness of cancer registration using suboptimal death certificate information.
Castro C, Bento MJ, Lunet N, Campos P.
Eur J Cancer Prev, 2012; 21(5): 478-9.